NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/18/2025
Back to search
Official data from USPTO
PSORIASIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
01/06/2026
Trademark type
Word
Nice classes
5
Filing date
09/19/1994
Registration date
07/16/1996
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/18/2025
Last transaction
01/06/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/15/1994
First use in commerce
09/15/1994
Drawing code
1
Owner type
16
Owner location
NILES, IL
Examiner
SMITH,LAURA E
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ALVA-AMCO PHARMACAL COMPANIES, LLC
ALVA-AMCO PHARMACAL COS., INC.
ALVA-AMCO PHARMACAL COS., INC.
Representatives
JAMES MICHAEL FAIER FAIER & FAIER PC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
non-prescription pharmaceutical preparations for the treatment of sumptoms of psoriasis and seborrheic dermatitis
Publications
History of USPTO decisions and trademark events.
30 publications found
RNL3
REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
12/18/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/18/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/18/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
09/10/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/16/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/17/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/12/2016
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
09/12/2016
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/12/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/12/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
06/21/2016
CFIT
CASE FILE IN TICRS
06/06/2007
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/04/2006
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/04/2006
PLGL
ASSIGNED TO PARALEGAL
10/03/2006
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
07/17/2006
E89R
TEAS SECTION 8 & 9 RECEIVED
07/17/2006
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/11/2002
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
01/30/2002
R.PR
REGISTERED-PRINCIPAL REGISTER
07/16/1996
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/20/1996
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/06/1996
IUAF
USE AMENDMENT FILED
01/26/1996
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
11/07/1995
PUBO
PUBLISHED FOR OPPOSITION
08/15/1995
NPUB
NOTICE OF PUBLICATION
07/14/1995
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/17/1995
CNEA
EXAMINER'S AMENDMENT MAILED
02/14/1995
DOCK
ASSIGNED TO EXAMINER
02/13/1995
Continuous trademark protection
Get notified about every new filing that threatens PSORIASIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.